Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker OGN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Juliana Papa Drinane Head of Mfg & Supply | OGN Organon & Co. | Sale | 14,761 | $13.57 | $200.3K Sale | Form 4 ↗ |
| May 6, 2026 | Lynette Holzbaur SVP and Corporate Controller | OGN Organon & Co. | Sale | 26,448 | $13.35 | $353.1K Sale | Form 4/A ↗ |
| Nov 12, 2025 | Carrie Smith Cox Executive Chair, Director | OGN Organon & Co. | Buy | 65,400 | $7.67 | $501.6K Buy | Form 4 ↗ |
| May 14, 2025 | Carrie Smith Cox Director | OGN Organon & Co. | Buy | 12,469 | $8.07 | $100.6K Buy | Form 4 ↗ |
| May 7, 2025 | Aaron Falcione Chief Human Resources Officer | OGN Organon & Co. | Buy | 5,500 | $8.77 | $48.2K Buy | Form 4 ↗ |
| May 6, 2025 | Kirke Weaver Gen. Counsel & Corp. Secy. | OGN Organon & Co. | Buy | 8,045 | $9.21 | $74.1K Buy | Form 4 ↗ |
| May 6, 2025 | Daniel Karp Executive VP, Corp. Dev. | OGN Organon & Co. | Buy | 3,500 | $8.24 | $28.8K Buy | Form 4 ↗ |
| May 5, 2025 | Matthew M. Walsh Chief Financial Officer | OGN Organon & Co. | Buy | 11,400 | $8.82 | $100.5K Buy | Form 4 ↗ |
| May 5, 2025 | Kevin Ali Chief Executive Officer, Director | OGN Organon & Co. | Buy | 34,000 | $8.81 | $299.5K Buy | Form 4 ↗ |
9 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:38 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances